Thursday, January 5, 2017

UPDATE 3-Halozyme's pancreatic cancer drug succeeds in mid-stage trial

Jan 5 (Reuters) - Halozyme Therapeutics Inc said

its lead experimental drug, in tandem with therapies from

Celgene Corp and Eli Lilly and Co, succeeded in

a mid-stage study involving patients with an...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)